4.8 Article

Modular Synthesis of Heparan Sulfate Oligosaccharides for Structure-Activity Relationship Studies

期刊

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 131, 期 47, 页码 17394-17405

出版社

AMER CHEMICAL SOC
DOI: 10.1021/ja907358k

关键词

-

资金

  1. Center for Research Resource of the National Institutes of Health [2 P41 RR005351]
  2. Human Frontier Science Program [RGP0062]
  3. Medical Research Council UK
  4. Biotechnology and Biological Sciences Research Council
  5. Biotechnology and Biological Sciences Research Council [BBS/B/13047, BB/D525713/1] Funding Source: researchfish
  6. Medical Research Council [G117/423] Funding Source: researchfish
  7. BBSRC [BB/D525713/1] Funding Source: UKRI
  8. MRC [G117/423] Funding Source: UKRI

向作者/读者索取更多资源

Although hundreds of heparan sulfate binding proteins have been identified and implicated in a myriad of physiological and pathological processes, very little information is known about the ligand requirements for binding and mediating biological activities by these proteins. This difficulty results from a lack of technology for establishing structure-activity relationships, which in turn is due to the structural complexity of natural heparan sulfate (HS) and difficulties of preparing well-defined HS oligosaccharides. To address this deficiency, we developed a modular approach for the parallel combinatorial synthesis of HS oligosaccharides that utilizes a relatively small number of selectively protected disaccharide building blocks, which can easily be converted into glycosyl donors and acceptors. The utility of the modular building blocks has been demonstrated by the preparation of a library of 12 oligosaccharides, which has been employed to probe the structural features of HS for inhibiting the protease, BACE-1. The complex variations in activity with structural changes support the view that important functional information is embedded in HS sequences. Furthermore, the most active derivative provides an attractive lead compound for the preparation of more potent compounds, which may find use as a therapeutic agent for Alzheimer's disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据